316 related articles for article (PubMed ID: 38000376)
1. 3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study.
Zhang H; Huang C; Gu X; Wang Y; Li X; Liu M; Wang Q; Xu J; Wang Y; Dai H; Zhang D; Cao B
Lancet Respir Med; 2024 Jan; 12(1):55-66. PubMed ID: 38000376
[TBL] [Abstract][Full Text] [Related]
2. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
[TBL] [Abstract][Full Text] [Related]
3. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
Huang C; Huang L; Wang Y; Li X; Ren L; Gu X; Kang L; Guo L; Liu M; Zhou X; Luo J; Huang Z; Tu S; Zhao Y; Chen L; Xu D; Li Y; Li C; Peng L; Li Y; Xie W; Cui D; Shang L; Fan G; Xu J; Wang G; Wang Y; Zhong J; Wang C; Wang J; Zhang D; Cao B
Lancet; 2021 Jan; 397(10270):220-232. PubMed ID: 33428867
[TBL] [Abstract][Full Text] [Related]
4. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.
Huang L; Yao Q; Gu X; Wang Q; Ren L; Wang Y; Hu P; Guo L; Liu M; Xu J; Zhang X; Qu Y; Fan Y; Li X; Li C; Yu T; Xia J; Wei M; Chen L; Li Y; Xiao F; Liu D; Wang J; Wang X; Cao B
Lancet; 2021 Aug; 398(10302):747-758. PubMed ID: 34454673
[TBL] [Abstract][Full Text] [Related]
5. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
Huang C; Huang L; Wang Y; Li X; Ren L; Gu X; Kang L; Guo L; Liu M; Zhou X; Luo J; Huang Z; Tu S; Zhao Y; Chen L; Xu D; Li Y; Li C; Peng L; Li Y; Xie W; Cui D; Shang L; Fan G; Xu J; Wang G; Wang Y; Zhong J; Wang C; Wang J; Zhang D; Cao B
Lancet; 2023 Jun; 401(10393):e21-e33. PubMed ID: 37321233
[TBL] [Abstract][Full Text] [Related]
6. Durability and cross-reactive immune memory to SARS-CoV-2 in individuals 2 years after recovery from COVID-19: a longitudinal cohort study.
Guo L; Zhang Q; Gu X; Ren L; Huang T; Li Y; Zhang H; Liu Y; Zhong J; Wang X; Chen L; Zhang Y; Li D; Fang M; Xu L; Li H; Wang Z; Li H; Bai T; Liu W; Peng Y; Dong T; Cao B; Wang J
Lancet Microbe; 2024 Jan; 5(1):e24-e33. PubMed ID: 38048805
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study.
Guo L; Wang G; Wang Y; Zhang Q; Ren L; Gu X; Huang T; Zhong J; Wang Y; Wang X; Huang L; Xu L; Wang C; Chen L; Xiao X; Peng Y; Knight JC; Dong T; Cao B; Wang J
Lancet Microbe; 2022 May; 3(5):e348-e356. PubMed ID: 35345417
[TBL] [Abstract][Full Text] [Related]
8. Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID).
Pazukhina E; Rumyantsev M; Baimukhambetova D; Bondarenko E; Markina N; El-Taravi Y; Petrova P; Ezhova A; Andreeva M; Iakovleva E; Bobkova P; Pikuza M; Trefilova A; Abdeeva E; Galiautdinova A; Filippova Y; Bairashevskaia A; Zolotarev A; Bulanov N; DunnGalvin A; Chernyavskaya A; Kondrikova E; Kolotilina A; Gadetskaya S; Ivanova YV; Turina I; Eremeeva A; Fedorova LA; Comberiati P; Peroni DG; Nekliudov N; Genuneit J; Reyes LF; Brackel CLH; Mazankova L; Miroshina A; Samitova E; Borzakova S; Carson G; Sigfrid L; Scott JT; McFarland S; Greenhawt M; Buonsenso D; Semple MG; Warner JO; Olliaro P; Osmanov IM; Korsunskiy AA; Munblit D;
BMC Med; 2024 Feb; 22(1):48. PubMed ID: 38302974
[TBL] [Abstract][Full Text] [Related]
9. Two-Year Health Outcomes in Hospitalized COVID-19 Survivors in China.
Yang X; Hou C; Shen Y; Zhang M; Zhang K; Wang F; Liu Y; Ma X; Cheng L; Kang J; Hu B; Wang M; Zeng L; Wang Y; He Y; Cao G; Jiang J; Jones P; Cao B; Li L
JAMA Netw Open; 2022 Sep; 5(9):e2231790. PubMed ID: 36107425
[TBL] [Abstract][Full Text] [Related]
10. Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors.
Gu X; Wang S; Zhang W; Li C; Guo L; Wang Z; Li H; Zhang H; Zhou Y; Liang W; Li H; Liu Y; Wang Y; Huang L; Dong T; Zhang D; Wong CCL; Cao B
EBioMedicine; 2023 Dec; 98():104851. PubMed ID: 37924708
[TBL] [Abstract][Full Text] [Related]
11. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
[TBL] [Abstract][Full Text] [Related]
12. Association of acute kidney injury with 1-year outcome of kidney function in hospital survivors with COVID-19: A cohort study.
Gu X; Huang L; Cui D; Wang Y; Wang Y; Xu J; Shang L; Fan G; Cao B
EBioMedicine; 2022 Feb; 76():103817. PubMed ID: 35074630
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.
He Z; Ren L; Yang J; Guo L; Feng L; Ma C; Wang X; Leng Z; Tong X; Zhou W; Wang G; Zhang T; Guo Y; Wu C; Wang Q; Liu M; Wang C; Jia M; Hu X; Wang Y; Zhang X; Hu R; Zhong J; Yang J; Dai J; Chen L; Zhou X; Wang J; Yang W; Wang C
Lancet; 2021 Mar; 397(10279):1075-1084. PubMed ID: 33743869
[TBL] [Abstract][Full Text] [Related]
14. Viral and antibody dynamics of acute infection with SARS-CoV-2 omicron variant (B.1.1.529): a prospective cohort study from Shenzhen, China.
Yang Y; Guo L; Yuan J; Xu Z; Gu Y; Zhang J; Guan Y; Liang J; Lu H; Liu Y
Lancet Microbe; 2023 Aug; 4(8):e632-e641. PubMed ID: 37459867
[TBL] [Abstract][Full Text] [Related]
15. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
16. Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study.
Wong CKH; Au ICH; Lau KTK; Lau EHY; Cowling BJ; Leung GM
Lancet; 2022 Oct; 400(10359):1213-1222. PubMed ID: 36216007
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Sequelae of COVID-19 Nearly 1 Year After Diagnosis.
Zhou F; Tao M; Shang L; Liu Y; Pan G; Jin Y; Wang L; Hu S; Li J; Zhang M; Fu Y; Yang S
Front Med (Lausanne); 2021; 8():717194. PubMed ID: 34888318
[No Abstract] [Full Text] [Related]
18. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.
Menni C; Valdes AM; Polidori L; Antonelli M; Penamakuri S; Nogal A; Louca P; May A; Figueiredo JC; Hu C; Molteni E; Canas L; Österdahl MF; Modat M; Sudre CH; Fox B; Hammers A; Wolf J; Capdevila J; Chan AT; David SP; Steves CJ; Ourselin S; Spector TD
Lancet; 2022 Apr; 399(10335):1618-1624. PubMed ID: 35397851
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
[TBL] [Abstract][Full Text] [Related]
20. [Short-term persistent symptoms in preschool children with mild/common coronavirus disease 2019 caused by Omicron variant infection after discharge: a follow-up study].
Hu CC; Xu P; Xu L; Zhang Y; Zhou JG; Wang LB; Zhou WH; Ye L; Lu CM
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Dec; 24(12):1289-1294. PubMed ID: 36544405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
